About prices, when CYCH around 14 area, someone bot 5,000 at 15 -- that person must have made a typo on their order. Very temporarily, the bid-ask, for however infinitessimily (i can't spell tonight - coming off the flu) small amount of time went from 14 x 15 in a rather tight mkt. Likely someone made a typo on ENMD.
Why the heck is everyone so hot and bothered about ENMD - still in phase II, still on mice. IMCL awaiting entry of phase III (and news today from CEO confirms it's coming), works on humans, 100% of persons in the trials had their tumors shrink by more than half, 88% had complete ie.100% disappearance of their tumours. Product is way closer to market than enmd. You heard the CEO it's a hundreds of millions market each year. Their drug C225 can be used in several areas of the body they believe, each needing separate FDA approval, so they have 'multi-products'. They have a lot of CASH - from their financial partner Merck. And yet ENMD's product very far behind, doesn't work, etc moves - only b/c ppl got overzealous a yr ago and so , remember the co's name. Well, their's a new name in town - IMCL ! |